Skip to main content
. Author manuscript; available in PMC: 2011 Jul 26.
Published in final edited form as: Toxicol Appl Pharmacol. 2008 Feb 6;229(3):265–272. doi: 10.1016/j.taap.2008.01.023

Figure 2. The ratio of [14C]CH equivalents in HDL to that in plasma and hepatic SRBI contents.

Figure 2

Treatments were as described in Figure 1. A. The ratio of [14C]CH equivalents in HDL to that in plasma. Values are expressed as mean ± SE. B. Hepatic SRBI contents. Corn oil or 15 mg CD/kg was treated to C57BL/6 mice. Hepatic plasma membrane fractions were prepared from animals (6 mice in each group) as described under “material and methods”. Hepatic SR-BI content was measured by western blotting with SRBI antibody. There were 6–7 mice in each group.* Indicates a statistically significant difference (p < 0.05) when compared with control.